For patients with acute coronary syndrome (ACS) symptoms, using a >30% relative change in cTnI level combined with the basal concentration or the concentration measured 6 h after hospitalization not only improves specificity, it also effectively assess the risk of cardiac events and death, which clearly has value for the prognosis of patients (11). Here, TNNI3 is linked to acute coronary syndrome.